1. Home
  2. CVCO vs ALKS Comparison

CVCO vs ALKS Comparison

Compare CVCO & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CVCO

Cavco Industries Inc. When Issued

HOLD

Current Price

$536.73

Market Cap

4.1B

ML Signal

HOLD

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$34.24

Market Cap

4.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CVCO
ALKS
Founded
1965
1987
Country
United States
Ireland
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
4.5B
IPO Year
1994
2012

Fundamental Metrics

Financial Performance
Metric
CVCO
ALKS
Price
$536.73
$34.24
Analyst Decision
Hold
Buy
Analyst Count
1
14
Target Price
$550.00
$43.43
AVG Volume (30 Days)
126.0K
2.3M
Earning Date
05-21-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
12.74
N/A
EPS
18.55
1.43
Revenue
$2,142,713,000.00
$1,475,899,000.00
Revenue This Year
$14.66
$24.26
Revenue Next Year
$7.70
$4.47
P/E Ratio
$28.94
$23.70
Revenue Growth
31.68
N/A
52 Week Low
$393.53
$25.17
52 Week High
$713.01
$36.48

Technical Indicators

Market Signals
Indicator
CVCO
ALKS
Relative Strength Index (RSI) 57.97 58.27
Support Level $488.88 $27.48
Resistance Level $548.97 $35.25
Average True Range (ATR) 14.50 0.96
MACD 4.30 -0.12
Stochastic Oscillator 75.41 56.72

Price Performance

Historical Comparison
CVCO
ALKS

About CVCO Cavco Industries Inc. When Issued

Cavco Industries Inc designs and produces factory-built homes under the Cavco Homes, Fleetwood Homes, and Palm Harbor Homes brands. It also produces modular homes, park model homes, and vacation cabins, as well as commercial structures, among others. The company operates principally in two segments: Factory-built housing, which includes wholesale and retail systems-built housing operations, and the Financial services segment, which includes manufactured housing consumer finance and insurance. Cavco receives a majority of its revenue from the Factory-built housing segment.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: